Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
Ultragenyx Pharmaceutical Inc. has partnered with GeneTx Biotherapeutics LLC to develop GTX-102, an antisense oligonucleotide (ASO), for the treatment...
RARE
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest RARE News
Research RARE on:
Ad Space